# Sempresto's community round is closing soon! | Sempresto

- Canonical URL: https://wefunder.com/feed/442272
- Entity ID: wefunder:feed_item:442272
- Published at: 2026-10-30 22:00:00 UTC
- Updated at: 2026-10-30 22:00:03 UTC

## Author
Elizabeth Reczek

## Subject
Sempresto

## Content
My co-founders and I started Sempresto because fewer than 40% of people with severe allergies have epinephrine on them when anaphylaxis hits. Our team has experienced this problem personally, and we knew that gap was fixable through better design. We’ve raised money toward proving that, and every person who joined our round is investing in making it possible.Invest or increase your investment: wefunder.com/sempresto Let’s give every allergy family the opportunity to live without fear. Best,LizElizabeth Reczek, PhDCo-Founder & CEO, SemprestoSempresto is an investigational product. It has not been approved by the FDA and is not available for sale.